Skip to content

Clinical trials

Completed Major Depressive Disorder trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Status: Completed Country / region: Australia Clear all

43 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20044
20061
20075
20084
20095
20102
20114
20121
20133
20143
20161
20171
20191
20201
20212
20222
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The University of New South Wales10
Alkermes, Inc.3
Bayside Health3
Eli Lilly and Company3
GlaxoSmithKline3
AstraZeneca2
Praxis Precision Medicines2
Takeda2
The Alfred2
Actinogen Medical1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder43
Depressive Disorder8
Mood Disorders6
Bipolar Disorder3
Anxiety Disorders2
Depressive Disorder, Treatment-Resistant2
Mental Disorders2
Anhedonia1
Cognitive Dysfunction1
Dysthymic Disorder1

Trials

Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.